Relmada Therapeutics
RLMD
RLMD
93 hedge funds and large institutions have $66.5M invested in Relmada Therapeutics in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 21 increasing their positions, 26 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.89% more ownership
Funds ownership: 45.55% → 47.44% (+1.9%)
19% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 26
Holders
93
Holding in Top 10
–
Calls
$907K
Puts
$602K
Top Buyers
| 1 | +$5.05M | |
| 2 | +$2.93M | |
| 3 | +$758K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$731K |
| 5 |
Millennium Management
New York
|
+$663K |
Top Sellers
| 1 | -$3.74M | |
| 2 | -$1.42M | |
| 3 | -$1.12M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.03M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$549K |